esorubicin has been researched along with Rectal Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giuliani, FC; Goldin, A; Kaplan, NO; Zirvi, KA | 1 |
| Aronne, T; Codacci Pisanelli, G; D'Amelio, R; Franchi, F; Manfredi, D; Mulieri, M; Seminara, P | 1 |
| Fiore, J; Kemeny, N; Raymond, V; Young, C | 1 |
| Falkson, G; Vorobiof, DA | 1 |
1 trial(s) available for esorubicin and Rectal Neoplasms
| Article | Year |
|---|---|
Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Clinical Trials as Topic; Colonic Neoplasms; Doxorubicin; Drug Evaluation; Female; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasm Metastasis; Rectal Neoplasms | 1986 |
3 other study(ies) available for esorubicin and Rectal Neoplasms
| Article | Year |
|---|---|
Chemotherapy of human colorectal tumor xenografts in athymic mice with clinically active drugs: 5-fluorouracil and 1-3-bis-(-2-chloroethyl)-1-nitrosourea (BCNU). Comparison with doxorubicin derivatives: 4'deoxydoxorubicin and 4'-O-methyldoxorubicin.
Topics: Adenocarcinoma; Animals; Carmustine; Colonic Neoplasms; Doxorubicin; Fluorouracil; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Rectal Neoplasms; Transplantation, Heterologous | 1981 |
Anthracycline in colorectal carcinoma: an in vitro short-term assay to predict drug sensitivity. Preliminary results.
Topics: Colonic Neoplasms; DNA, Neoplasm; Doxorubicin; Drug Evaluation, Preclinical; Drug Resistance; Epirubicin; Humans; In Vitro Techniques; Liver Neoplasms; Rectal Neoplasms; RNA, Neoplasm | 1987 |
Phase II study of 4'-deoxydoxorubicin in advanced colorectal cancer.
Topics: Adult; Aged; Blood Cell Count; Bone Marrow; Carcinoma; Colonic Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Humans; Middle Aged; Nausea; Rectal Neoplasms | 1986 |